希望大家能帮我翻译一下,但不要机器翻译,谢谢了

来源:百度知道 编辑:UC知道 时间:2024/05/29 01:27:53
Of all the recent refusals of corporate leaders to apologize, perhaps none is more striking than that of Raymond Gilmartin, CEO of Merck from 1994 to 2005, Merck performed well during the first half of Gilmartin’s tenure, but it stumbled badly on the back nine. ( on the last trading day of 2000, Merck shares closed at $88.61; on Gilmartin’s last day at the helm, May 5, 2005, the stock closed at $34.75). Notably, Gilmartin’s last months were clouded by what at this writing threatens to be a calamity: some 7,000 lawsuits against Merck, involving the use of its painkiller Vioxx.
The New York Times observed that as the company’s Vioxx crisis deepened- the drug has recently been linked in FDA research by David Graham to up to 139,000 heart attacks or deaths arising from cardiac causes- Gilmartin appeared to freeze. Not only did he not apologize; he could hardly get himself to address the issue. And when he did, he was defensive. He insisted that Merck had demonstrated “consistent an

所有最近拒绝企业领袖道歉,可能无显比先生Gilmartin董事长默克1994年至2005年商品成效上半年Gilmartin的所有权,但发现严重背九. (2000年的最后交易日,与默克下午88.61元; Gilmartin在最后一天的领导,2005年5月5日的34.75元证券关闭. 特别是Gilmartin最后月云所撰写的可能是一场灾难,有7000起诉默克涉及Vioxx药物的使用. <纽约时说,该公司Vioxx危机加深的药物最近在与美国研究大卫Graham至139人死亡或心脏病引起的心脏原因,出现Gilmartin冻结. 不但不道歉. 他自己无法得到处理. 当他和他的防御. 他坚持签定表明"一贯严格遵守科学研究、透明度和公正性,并散发攻击对手"完全错误的信息,有时. Gilmartin在辞职的提前,他没有任何表示遗憾和负责.